ARIAD Pharma (ARIA) Tops Q3 EPS by 7c
Get Alerts ARIA Hot Sheet
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $42.93 million.
ARIAD Pharma reaffirmed FY2016 guidance.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Towne Bank (TOWN) Reports In-Line Q1 EPS
- Towne Bank (TOWN) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!